National Pension Service Purchases 16,835 Shares of Zoetis Inc. (NYSE:ZTS)

National Pension Service raised its position in shares of Zoetis Inc. (NYSE:ZTS) by 2.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 799,063 shares of the company’s stock after purchasing an additional 16,835 shares during the quarter. National Pension Service owned 0.17% of Zoetis worth $157,711,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Bogart Wealth LLC boosted its position in shares of Zoetis by 9,510.0% during the fourth quarter. Bogart Wealth LLC now owns 24,986 shares of the company’s stock valued at $4,931,000 after buying an additional 24,726 shares during the last quarter. Picton Mahoney Asset Management raised its holdings in shares of Zoetis by 1.6% during the fourth quarter. Picton Mahoney Asset Management now owns 85,237 shares of the company’s stock valued at $16,825,000 after purchasing an additional 1,370 shares during the last quarter. EdgeRock Capital LLC bought a new position in Zoetis during the fourth quarter valued at approximately $45,000. Everpar Advisors LLC bought a new stake in Zoetis in the 4th quarter worth approximately $296,000. Finally, Gryphon Financial Partners LLC grew its position in Zoetis by 11.8% in the 4th quarter. Gryphon Financial Partners LLC now owns 3,056 shares of the company’s stock worth $601,000 after purchasing an additional 322 shares during the period. 92.80% of the stock is currently owned by institutional investors.

Zoetis Trading Down 2.1 %

ZTS traded down $3.53 during trading on Wednesday, reaching $164.92. The company had a trading volume of 4,669,191 shares, compared to its average volume of 3,195,939. The company has a quick ratio of 1.94, a current ratio of 3.33 and a debt-to-equity ratio of 1.30. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The stock has a market cap of $75.25 billion, a P/E ratio of 31.78, a PEG ratio of 2.57 and a beta of 0.86. The business has a 50 day simple moving average of $167.64 and a 200-day simple moving average of $178.93.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.04. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The business had revenue of $2.19 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same quarter in the previous year, the business earned $1.31 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, equities analysts anticipate that Zoetis Inc. will post 5.77 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ZTS. Stifel Nicolaus dropped their price objective on shares of Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. HSBC dropped their price target on shares of Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday. Piper Sandler reaffirmed an “overweight” rating and issued a $195.00 target price (down from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. Barclays cut their price target on Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 23rd. Finally, The Goldman Sachs Group lowered their price target on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a report on Monday. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $211.75.

Insiders Place Their Bets

In other Zoetis news, EVP Roxanne Lagano sold 923 shares of the firm’s stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $151.17, for a total transaction of $139,529.91. Following the transaction, the executive vice president now directly owns 14,800 shares in the company, valued at approximately $2,237,316. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 2,209 shares of company stock worth $371,293 in the last three months. Corporate insiders own 0.16% of the company’s stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.